| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |